The importance of vitamins D and K for the bone health and immune function in inflammatory bowel disease

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 6, 2012, Pages 635-640

  Iijima, Hideki ^a   Shinzaki, Shinichiro ^a   Takehara, Tetsuo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

bone mineral density; inflammatory bowel disease; mucosal inflammation; vitamin D; vitamin K

Indexed keywords

CALCITRIOL; CASPASE RECRUITMENT DOMAIN PROTEIN 15; COLECALCIFEROL; ERGOCALCIFEROL; INTERLEUKIN 10; INTERLEUKIN 6; OSTEOCALCIN; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D; VITAMIN K GROUP;

BONE DENSITY; BONE METABOLISM; CELL DIFFERENTIATION; COLITIS; CROHN DISEASE; DENDRITIC CELL; DIETARY INTAKE; ENTERITIS; GENE FREQUENCY; GENE MUTATION; HUMAN; IMMUNE RESPONSE; METABOLIC BONE DISEASE; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL INTESTINE RESECTION; STEATORRHEA; TH17 CELL; ULCERATIVE COLITIS; ULTRAVIOLET B RADIATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

BONE AND BONES; BONE DENSITY; CLINICAL TRIALS AS TOPIC; CYTOKINES; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; SUNLIGHT; T-LYMPHOCYTES; VITAMIN D; VITAMIN K;

ANIMALIA;

EID: 84868197635     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328357f623     Document Type: Review

References (43)

1. Renz H, Brandtzaeg P, Hornef M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol 2012; 12:9-23.
2. Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011; 140:1729-1737.
3. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474:298-306.
4. Agrawal M, Arora S, Li J, et al. Bone, inflammation, and inflammatory bowel disease. Curr Osteoporos Rep 2011; 9:251-257.
5. Bjarnason I, Macpherson A, Mackintosh C, et al. Reduced bone density in patients with inflammatory bowel disease. Gut 1997; 40:228-233.
6. Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987; 28:410-415.
7. Froicu M, Weaver V, Wynn TA, et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003; 17:2386-2392.
8. Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol 2006; 92:60-64.
9. Van Etten E, Decallonne B, Verlinden L, et al. Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators. J Cell Biochem 2003; 88:223-226.
10. Ohsaki Y, Shirakawa H, Hiwatashi K, et al. Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Biosci Biotechnol Biochem 2006; 70:926-932.
11. Reddi K, Henderson B, Meghji S, et al. Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine 1995; 7:287-290.
12. Ghishan FK, Kiela PR. Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol 2011; 300:G191-G201.
13. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
14. Ulitsky A, Ananthakrishnan AN, Naik A, et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr 2011; 35:308-316.
15. El-Matary W, Sikora S, Spady D. Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Dig Dis Sci 2011; 56:825-829.
16. Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin d status is associated with reduced risk of Crohn's disease. Gastroenterology 2012; 142:482-489.
17. Vagianos K, Bernstein CN. Homocysteinemia and B vitamin status among adult patients with inflammatory bowel disease: a one-year prospective follow-up study. Inflamm Bowel Dis 2012; 18:718-724.
18. Hwang C, Ross V, Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm Bowel Dis 2012. [Epub ahead of print]
19. Lim WC, Hanauer SB, Li YC. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 2005; 2:308-315.
20. Simmons JD, Mullighan C, Welsh KI, et al. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 2000; 47:211-214.
21. Noble CL, McCullough J, Ho W, et al. Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2008; 27:588-596.
22. Bentley RW, Keown D, Merriman TR, et al. Vitamin D receptor gene polymorphism associated with inflammatory bowel disease in New Zealand males. Aliment Pharmacol Ther 2011; 33:855-856.
23. Eloranta JJ, Wenger C, Mwinyi J, et al. Association of a common vitamin Dbinding protein polymorphism with inflammatory bowel disease. Pharmacogenet Genomics 2011; 21:559-564.
24. American Gastroenterological Association medical position statement. Guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 2003; 124:791-794.
25. Abreu MT, Kantorovich V, Vasiliauskas EA, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 2004; 53:1129-1136.
26. Nakajima S, Iijima H, Egawa S, et al. Association of vitamin K deficiency with bone metabolism and clinical disease activity in inflammatory bowel disease. Nutrition 2011; 27:1023-1028.
27. Benchimol EI, Ward LM, Gallagher JC, et al. Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007; 45:538-545.
28. Miheller P, Muzes G, Hritz I, et al. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm Bowel Dis 2009; 15:1656-1662.
29. Cantorna MT. Mechanisms underlying the effect of vitamin D on the immune system. Proc Nutr Soc 2010; 69:286-289.
30. Bruce D, Yu S, Ooi JH, et al. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol 2011; 23:519-528.
31. Cantorna MT, Munsick C, Bemiss C, et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000; 130:2648-2652.
32. Daniel C, Sartory NA, Zahn N, et al. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008; 324:23-33.
33. Wang TT, Dabbas B, Laperriere D, et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem 2010; 285:2227-2231.
34. Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq defined genomewide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010; 20:1352-1360.
35. Jorgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn's disease: a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 2010; 32:377-383.
36. Gundberg CM, Lian JB, Booth SL. Vitamin k-dependent carboxylation of osteocalcin: friend or foe? Adv Nutr 2012; 3:149-157.
37. Cravo M, Guerreiro CS, dos Santos PM, et al. Risk factors for metabolic bone disease in Crohn's disease patients. InflammBowel Dis 2010; 16:2117-2124.
38. Kuwabara A, Tanaka K, Tsugawa N, et al. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int 2009; 20:935-942.
39. Swidsinski A, Loening-Baucke V, Vaneechoutte M, et al. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 2008; 14:147-161.
40. Fang Y, Hu C, Tao X, et al. Effect of vitamin K on bone mineral density: a metaanalysis of randomized controlled trials. J Bone Miner Metab 2012; 30:60-68.
41. Shea MK, Booth SL, Massaro JM, et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2008; 167:313-320.
42. Hurtado B, de Frutos PG. GAS6 in systemic inflammatory diseases: with and without infection. Crit Care 2010; 14:1003.
43. Rothlin CV, Lemke G. TAM receptor signaling and autoimmune disease. Curr Opin Immunol 2010; 22:740-746.